Kestra Medical Technologies, Ltd. Common Stock (KMTS) — Cash Flow-to-Debt Ratio
Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a Cash Flow-to-Debt Ratio of -0.20x as of January 2026, meaning its operating cash flow of $-18.37 Million could theoretically repay 0% of its total liabilities ($91.35 Million) in one year. Explore KMTS cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kestra Medical Technologies, Ltd. Common Stock Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for Kestra Medical Technologies, Ltd. Common Stock across 5 annual periods. Also explore Kestra Medical Technologies, Ltd. Common assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kestra Medical Technologies, Ltd. Common Stock (2020–2025)
Year-by-year debt coverage analysis for Kestra Medical Technologies, Ltd. Common Stock. For market capitalisation and broader financial context, see market value of Kestra Medical Technologies, Ltd. Common.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.86x | $-77.61 Million | $90.34 Million | ▼ -203.7% |
| 2024 | -0.28x | $-72.23 Million | $255.33 Million | ▲ +36.5% |
| 2023 | -0.45x | $-69.64 Million | $156.23 Million | ▲ +57.1% |
| 2021 | -1.04x | $-29.89 Million | $28.76 Million | ▲ +86.2% |
| 2020 | -7.54x | $-30.29 Million | $4.02 Million | — |